TC BioPharm (Holdings) plc is a biotechnology company focused on developing innovative cell therapies for the treatment of cancer and other serious diseases

The company specializes in harnessing the power of the immune system, specifically employing techniques involving gamma delta T-cells, to create advanced therapeutics aimed at enhancing patient outcomes. Through rigorous research and clinical trials, TC BioPharm is dedicated to bringing transformative treatments to patients suffering from a variety of conditions, ultimately striving to improve healthcare and expand therapeutic options in the field of oncology and beyond.